Compare FMC Corp (FMC) vs Symbotic Inc (SYM) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

SYM trades at $42.10, down 3.57% today, with a bearish technical signal. The company reported revenue of $2.25B in 2025 but a net loss of $16.94M, though gross margins improved to 20.43%. Recent news highlights expansion in warehouse robotics and an upcoming Q3 earnings report on August 5, 2026.

Analyst consensus is bullish with a $57.50 price target, but high valuation ratios and recent earnings miss pose risks. Positive cash flow and strategic acquisitions offer growth potential, yet profitability challenges and competitive pressures remain key concerns for investors.